Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) EBT Margin (2019 - 2020)

Alx Oncology Holdings' EBT Margin history spans 2 years, with the latest figure at 2146.3% for Q2 2020.

  • On a quarterly basis, EBT Margin fell 182282.0% to 2146.3% in Q2 2020 year-over-year; TTM through Mar 2021 was 3451.99%, a 298967.0% decrease, with the full-year FY2020 number at 800.08%, down 39956.0% from a year prior.
  • EBT Margin hit 2146.3% in Q2 2020 for Alx Oncology Holdings, down from 832.06% in the prior quarter.
  • Over the last five years, EBT Margin for ALXO hit a ceiling of 241.72% in Q3 2019 and a floor of 2146.3% in Q2 2020.